Symplicity-3 hypertension trial: Basic and clinical insights

doi:10.5494/wjh.v5.i2.74

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6541)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

318

WORD

369

HTML

3029

Figures (1-4)

332

Sum=4048

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1034

Download

1459

Sum=2493

May 23, 2015 (publication date) through Mar 3, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hypertension

ISSN

2220-3168

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hypertens. May 23, 2015; 5(2): 74-78
Published online May 23, 2015. doi: 10.5494/wjh.v5.i2.74

Full Size Figure Download Figure

Figure 3 After ablation of the ganglionated plexi at the pulmonary vein-atrial junctions the same level of high frequency stimulation failed to elicit any parasympathetic response and no slowing of the ventricular rate. Traces are the same as in figure 2. See text for further discussion. GP: Ganglionated plexi; HFS: High-frequency stimulation.

Citation: Scherlag BJ, Po SS. Symplicity-3 hypertension trial: Basic and clinical insights. World J Hypertens 2015; 5(2): 74-78
URL: https://www.wjgnet.com/2220-3168/full/v5/i2/74.htm
DOI: https://dx.doi.org/10.5494/wjh.v5.i2.74